The objection of John M Desmarais does not surprise me. It will be interesting on the ruling. I somehow get the feeling that his motivation is to buyout all the assets of BioRestorative Therapies Inc. Why else would he start his own stem cell research company (as stated in the “stalking Horse” disclosure filled in a previous court filling) and then propose to buy all assets. I think there is more to this than what has and can be disclosed.
You have the best trial lawyer for patents and IP’s going against an attempt to reorganize BRTXQ. He sat on the board of directors for 5 years, so yes, he knows the the company extremely well... to well, in my opinion. Yes he loaned money to BRTXQ; however, he also knowns the value of the technology within the company. Why else does he want it for his stem cell research company. Tell me if I’m way off here or not.
Mr. Desmarais must have confidence in the stem cell therapies to want to own all the assets. This alone tells me that there is a future for this company if the necessary funds are raised and BRTXQ emerges from bankruptcy. Not to mention the value to stakeholders as the company gets back to business and starts phase 2 trials. Furthermore, if phase 2 is successful, I believe funding for a phase 3 trial will not be as difficult as Mr. Desmarais implies.
For shareholders, if BRTXQ can emerge form bankruptcy, will realize an increase in share price. However, I don’t think it will be a crazy spike in price. It will take time for investor confidence to fully recover. We are still in the wait and see mod for now. We can only hope and pray for the best in the days to come.
